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Although a growing body of research suggests that mind-body therapies may be appropriate to integrate into the treatment of
depression, studies consistently lack methodological sophistication particularly in the area of control groups. In order to better
understand the relationship between control group selection and methodological rigor, we provide a brief review of the literature
on control group design in yoga and tai chi studies for depression, and we discuss challenges we have faced in the design of control
groups for our recent clinical trials of these mind-body complementary therapies for women with depression. To address the
multiple challenges of research about mind-body therapies, we suggest that researchers should consider 4 key questions: whether
the study design matches the research question; whether the control group addresses performance, expectation, and detection bias;
whether the control group is ethical, feasible, and attractive; and whether the control group is designed to adequately control for
nonspecific intervention effects. Based on these questions, we provide specific recommendations about control group design with
the goal of minimizing bias and maximizing validity in future research.
1. Introduction
As the state of the science progresses in the field of com-
plementary and alternative medicine (CAM), it is imperative
for researchers to develop well-designed clinical trials that
clearly and systematically develop a base of evidence to
support effects and efficacy ofmind-body therapies. Yoga and
tai chi are two mind-body therapies that hold promise as
complementary therapeutic interventions for clinical condi-
tions such as depression. It is relevant and important to test
these interventions with appropriately designed randomized
controlled trials (RCTs). However, numerousmethodological
issues have been cited in research in this area, such as a
lack of consistency between research question and design,
unclear treatment protocols and reporting of findings, and
lack of appropriate bias controls, among others (for additional
perspectives on general methodological challenges with var-
ious mind-body modalities, see [1–7]). Although guidelines
have been proposed for the development of yoga and tai chi
interventions for randomized trials and recommendations
have been made about the appropriate reporting of research
findings, one important methodological dilemma that has
remained largely unexplored in the literature is the issue of
appropriate control group design [4, 7, 8].
Because control group design continues to be a challenge
for researchers, the purpose of this paper is to provide
perspectives on important considerations and make rec-
ommendations about control group design in mind-body
therapy research.Themotivation for this paper arose because
of the challenges faced by these authors in the design
of control groups for their recent clinical trials of mind-
body complementary therapies for women with depression.
Examples from related research studies and “lessons learned”
from our studies will be provided in order to elucidate some
of the more salient issues in control group design. While
the majority of the literature cited focuses on two mind-
body therapies, yoga and tai chi, the control group dilemmas
elucidated here are applicable to other mind-body research.
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2. Methods and Results
2.1. Control Group Defined. It is one of the most basic yet
critical aspects of an RCT; control groups are necessary for
discriminating treatment outcomes from outcomes related to
other factors, such as the natural history of a disease process
and participant or researcher expectations. If a participant
experiences a clinical improvement during a study, a well-
designed study with an appropriate control group will enable
the improvements to be attributed to the intervention itself,
thus strengthening the validity and credibility of the findings.
As such, the design of a control group is as critical as the
design of the intervention group.
2.2. Control Group Design in Pharmaceutical Research.
Although pharmaceutical research designs may be more
straightforward than designs for examining multifaceted
mind-body interventions, a brief examination of control
group design in pharmaceutical research provides relevant
context. The Food and Drug Administration (FDA) is clear
about the need for “adequate and well-controlled” examina-
tions of the effects of a particular treatment in drug studies
[9]. The FDA suggests that there are five types of control
groups appropriate for rigorous studies [10]: the concurrent
placebo; the no-treatment concurrent control; the dose-
response concurrent control; the active/positive concurrent
control; and the external/historical control. The FDA states
that, although these various types of control groups may
be relevant in various contexts, there are certain caveats
for each of them. First, placebo-only control groups are
not recommended when effective and established treatments
exist for ethical reasons. Second, the no-treatment control
group is only reasonable when the study outcomes are
completely objective and cannot be influenced by the lack
of blinding. The dose-response concurrent control is used to
compare groups’ responses to variable doses of the drug and
can be valuable only after initial testing. Fourth, the use of
an active control group requires focusing on outcomes that
are clinically important because there may not be very large
effect sizes or obvious statistical significance of differences
in outcomes. Importantly, active control group designs pose
fewer ethical dilemmas than placebo controls, particularly
when a new treatment is expected to be at least as good as
the existing treatment.
2.3. Control GroupDesign inMind-BodyResearch. Thedesign
of control groups in clinical trials with nonpharmacolog-
ical, psychosocial, and/or behavioral interventions is often
much more complex than those of drug studies. Researchers
investigating mind-body complementary interventions for
clinical conditions have a number of challenges in optimal
study design, predominantly because these interventions are
typically multifaceted and complex (e.g., they often involve
multiple components: behavioral, psychosocial, and educa-
tional).Many of the control group options listed above are not
appropriate for this type of research; for example, the placebo
control is often not feasible because mind-body therapies
do not typically have an obvious placebo or “sham” inter-
vention. Researchers of mind-body therapies involving psy-
chosocial/behavioral interventions are challenged to identify
appropriate psychosocial or behavioral “placebos” because
the active/inactive components of interventions are not as
apparent as they are for medications [11]. Additionally, a no-
treatment control group is often unethical when conducting
research with clinical populations (such as individuals with
depression) because there is typically a known effective ther-
apy or a minimum level of “usual care” expected depending
upon the severity of the clinical condition.
Given these caveats, the most common types of control
group conditions used in research involving mind-body
interventions include (1) the “usual care control,” whereby
participants receive the usual care for the clinical condition,
(2) the “wait-list control,” whereby participants will receive
the usual care and will later receive the intervention in
addition to the usual care, (3) the “active control,” whereby
the control group receives an activity or intervention which
controls for some aspect of attention, time, or expectation,
and (4) the “dismantling” or “add-on” control, where com-
ponents of an existing intervention are isolated or added
on in an attempt to identify the essential mechanism of
action [11, 12]. However, specific challenges are often present
with these types of control groups in mind-body research,
as seen in the literature and in our experiences with recent
RCTs involving yoga and tai chi discussed below. It should
be noted that the National Center for Complementary and
Alternative Medicine defines mind-body practices as those
which promote health by facilitating interactions among the
brain, mind, body, and behavior (e.g., meditation, yoga, tai
chi, guided imagery, and others) [11]; we focus herein on
two specific mind-body therapies, yoga and tai chi, that are
receiving increasingly more attention in the research and lay
communities for their potential effects in depressed patients
[13].
2.3.1. Control Groups in Yoga for Depression Studies. A review
of RCTs of yoga as amind-body complementary intervention
for depression reveals that the design of control groups is
highly varied (Table 1). The most common type of compar-
ison group is the usual care or wait-list control where no
changes were made to the typical activities of the participants
in those groups [14–16]. Three out of the six studies used
some sort of active control.The study byButler and colleagues
used a psychoeducational activity as the active control group
in which participants were to read a book and pamphlets
provided to them [17]. The attention from study staff was
quite different between the two groups, whereby the control
group did not involve any group or individual sessions, yet the
intervention groups both had 20 hours of interactions with
other participants and research staff. The study by Sharma
and colleagueswas unique in its use of an active control which
is not commonly used in yoga research. In this case, a “sham”
activity was designed to mimic the movements and stillness
of the yoga intervention but details about the components
of both the intervention and control group are lacking [18].
Finally, one study compared the use of a specific type of yoga
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Table 1: Comparison of intervention and control group conditions in community-based RCTs of yoga for adults with depression.
Author, date Intervention group(s) Control group(s)
Woolery et al.
(2004) [16] Group class: Iyengar yoga 1 hour twice per week × 5 weeks Wait-list control
Sharma et al.
(2006) [18]
Home practice after initial group training: Sahaja yoga
(meditation with specific hand movements) 30 minutes
three times per week × 8 weeks
Placebo control: sham meditation control (hands in
different positions, sitting with eyes closed) 30 minutes
three times per week × 8 weeks
Butler et al.
(2008) [17]
(a) Group class: Hatha yoga + psychoeducation 2 hours
per week × 8 weeks + plus 4-hour booster session at week
12; home practice: 30 minutes daily 6 days per week
recommended with manual and tapes
(b) Group class: hypnosis + psycho-education 90 minutes
per week × 10 weeks plus 4-hour booster at week 12
Active control: psycho-education alone (reading
materials—no group sessions)
Krishnamurthy
and Telles
(2007) [15]
(a) Group class: yoga 30 minutes per week × 24 weeks
(b) Ayurveda herbal therapies Wait-list control
Field et al.
(2012) [14]
(a) Group class: yoga 20 minutes per week × 12 weeks
(b) Individual massages 20 minutes per week × 12 weeks
(delivered by researchers)
Usual care control
Shahidi et al.
(2011) [19] Group Laughter yoga 30 minutes × 10 sessions
(a) Active control: group exercise 30 minutes × 10 sessions
(b) Usual care control
The literature review inclusion criteria: community-based, randomized, and controlled studies published in 2000–2012; English; participants with confirmed
diagnosis of depression/dysthymia or high levels of depressive symptoms; yoga intervention group. Exclusion criteria: participants whowere inpatient/hospital-
based; had no clinical or confirmatory diagnosis of depression/dysthymia; nonrandomized and noncontrolled designs; participants were excluded if they
reported a psychiatric diagnosis.
(Laughter Yoga) in Iranian elderly depressed women to two
control groups a usual care control and an exercise control
group [19]. The exercise group (jogging and stretching) did
control for attention and time, by mirroring the number and
length of the yoga group sessions.
Although many research studies have sought to examine
the efficacy and effectiveness of yoga for depressed individu-
als, the control group design has been inconsistent and often
not thoroughly discussed. Furthermore, it is unclear whether
the control groups used in these studies were able to control
for “co-intervention” or the unequal attention given to the
yoga group [6]. In almost all of these studies, equivalent time
and attentionwere not provided to the control group.As such,
one must consider whether the outcomes of interest were
affected.
2.3.2. Control Groups in Tai Chi for Depression Studies. A
review of RCTs of tai chi as a mind-body complementary
therapy for depression also reveals that the design of control
groups is varied, including no-treatment control, wait-list
control, and active control groups (Table 2). A total of three
of the five studies meeting the search criteria employed wait-
list control groups and the treatment/wait-list conditions
lasted three months [20–22]. In a wait-list control group
design, participants assigned to the control group served as
the untreated comparison for the treatment group and later
received the intervention. The other two studies used active
control groups. Lavretsky and colleagues sought to examine
the potential benefit of tai chi in partial responders to the
drug escitalopram [23]. The active control group involved
a health education activity; the authors rationalized this
because they wanted to determine if tai chi would have a
clinical benefit independent of other treatment factors such
as expectation and group support. Cheng and colleagues ran-
domized participants to receive either the tai chi class (first
intervention group) or to play a game of mahjong (second
intervention group) or to participate in the handicraft group
(control group)which consisted of connecting beads together
to create interesting shapes [24]. Each activity was performed
for one hour three times a week for 12 weeks. This handicraft
activity was designed to control for group effect.
This brief, focused review of the literature provides
evidence that a variety of control group conditions are being
employed in studies of tai chi for depression.While it is useful
that the various authors have acknowledged the challenges
in selecting an appropriate control group by explaining
their choices, there is not a clear answer for the strongest
control group design. The wait-list control group design is a
reasonable design but does introduce potential bias given the
sense of expectancy it creates in the control group.The active
control group chosen was well-documented andmatched the
time and attention given to the tai chi intervention group.
2.3.3. Lessons Learned from a Recent Study on Yoga for Depres-
sion. We recently conducted a small RCT to evaluate the
feasibility, acceptability, and effects of yoga for women with
major depressive disorder (MDD) and residual symptoms
despite the usual care [25]. Conducted in a convenience
sample of 27 women, this community-based prospective,
randomized, and controlled pilot study used a mixed-
methods approach in comparing an 8-week gentle Hatha
yoga intervention and an active control activity. In the
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Table 2: Comparison of intervention and control group conditions in community-based RCTs of tai chi for adults with depression.
Author, date Intervention group(s) Control group(s)
Chou et al. (2004) [20] 45 minute tai chi class 3 times weekly for 3 months Wait-list control
Cho (2008) [21] 3 tai chi classes per week for 3 months Wait-list control
Lavretsky et al. (2011)
[23] 2-hour tai chi class weekly for 10 weeks
Active control: health education
attention-control 2-hour class weekly for
10 weeks
Cheng et al. (2012) [24] 1-hour tai chi class or mahjong game 3 times weekly for 3months Active control: handicrafts
Yeung et al. (2012) [22] 1-hour class twice weekly for 12 weeks Wait-list control
The literature review inclusion criteria: community-based, randomized, and controlled studies published in 2000–2012; English; participants with confirmed
diagnosis of depression; tai chi intervention group. Exclusion criteria: participants were inpatient/hospital-based; no clinical or confirmatory diagnosis of
depression; non-randomized and non-controlled design; participants were excluded if they reported a psychiatric diagnosis.
yoga intervention group, participants took part in once-
weekly 75-minute group classes for 8 weeks; they were also
encouraged to do yoga daily at home using handouts and/or
a provided DVD. In the attention-control group, participants
engaged in a series of weekly 75-minute health education
sessions involving lectures, discussions, and videos for 8
weeks; participants were also encouraged to review the health
concepts at home using provided handouts and websites.
Both groups had an equivalent numbers of visits (screening,
intervention points, data collection) and phone contacts with
study staff.
The design of the active control group seemed reasonable
and appropriate for several reasons. Although the majority of
the recent RCTs on yoga for depression have used usual care
or wait-list controls, health education sessions were chosen
as an active control activity because the depression inter-
vention literature suggests that health education sessions are
reasonable activities with depressed participants and have
been effective in retaining control group participants in this
manner [26–32]. Additionally, the health education sessions
provided equivalent group class time and exposure to study
staff. Both groups were provided with handouts and were
equally expected to complete the “homework.” Participants
in the attention-control group had equal face-to-face time
with other participants, in the attempt to control for the
effect of group interactions. To maintain internal validity, the
lectures and videos were designed to avoid content overlap
with material presented in the yoga intervention. Because
the yoga intervention was comprised of both behavioral and
psychoeducational components (physical activity, breathing,
relaxation, and discussions of incorporation of yogic princi-
ples into daily life), the control group activity was designed to
exclude this content, such that the control activity involved
only psychoeducation about wellness topics. Finally, the
active control group involved group discussions and videos
in the attempt to be interesting enough to retain participants.
Both groups received a small compensation for completion of
the study to minimize overall attrition.
Despite the fact that the control group intervention was
designed thoughtfully and purposefully, we experienced a
number of challenges with the control group. First, there
was a higher attrition rate in the control group, perhaps
due to disappointment of not being randomized into the
yoga group. Because part of the informed consent process
involved informing potential participants about both groups,
it was impossible to blind participants to the fact that yoga
was a possible intervention. Second, by learning about and
discussing healthy behaviors in the weekly sessions, the
control group participants ended upmakingmore significant
behavior changes than was expected for an 8 week interven-
tion. For example, a number of participants engaged in close
social support and started going to the gym and attending
group psychotherapy sessions together. The fact that these
participants had significant decreases in depressionmay have
been partly related to the health education sessions, but
even more likely they were related to the social support and
discussions between the women. Third, social support may
have been stronger in the health education group because
more timewas allowed for discussion in class. As such, getting
women together on a weekly basis may have become an
intervention in and of itself, a subtle form of group therapy,
ultimately diluting and confounding the findings.
2.3.4. Lessons Learned from a Clinical Trial of Tai Chi in
Women with Breast Cancer. Tai chi was one of two interven-
tions in a longitudinal RCT in women with early stage breast
cancer during the period of chemotherapy. A study aim was
to compare the effects of tai chi to a spiritual growth group
and a no-treatment control that received standard care on
psychosocial functioning including depression. Recruitment
and retention presented significant challenges in this study
in part due to the timing of the intervention as well as
the standard care control group. The enrollment of women
into a longitudinal study while they were in the process
of acclimating to the diagnosis of breast cancer as well as
making difficult treatment decisions impacted recruitment
and retention. Additionally, although women were intrigued
by the opportunity to participate in a study involving tai chi
and spiritual growth groups, their interest seemed to wane
when assigned to the usual care control group, thus creating
further challenges with retention. While a wait-list design
was not possible because of the longitudinal study design, an
active/attention-control group such as general breast cancer
related health education might have helped with recruitment
and retention.
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Table 3: Considerations about types of control groups in studies of mind-body therapies.
Control groups Pros Cons
Usual care control (i) Ethical
(i) Variability in usual care for depression according to
the individual
(ii) Attrition
Wait-list control (i) Ethical(ii) Enhance recruitment and retention
(i) Expectation bias
(ii) Does not allow for blinding of participants to
hypothesis
(iii) Extends study time
(iv) Waiting too long for intervention may lead to
attrition
(v) No control for non-specific treatment effects
Active control
(i) Ethical
(ii) Enhance recruitment and retention
(iii) May allow for blinding of participants to
hypothesis
(iv) Control for threats to internal validity
(i) Must exactly parallel treatment group in time and
attention
(ii) May become an intervention in and of itself
(iii) May be more difficult to detect treatment effect
3. Discussion: Considerations and
Recommendations for Future Research
A growing evidence base indicates that certain mind-body
therapies may be appropriate in patients with depression, yet
almost every integrated review ormeta-analysis finds that the
literature lacks methodological rigor including the lack of an
appropriate control. Although the double- or triple-blinded
RCT has historically been considered the “gold standard” in
considering the quality of research, this design does typically
not lend itself well to mind-body intervention studies. That
said careful design of these studies is critical if we are to
be able to evaluate the effectiveness of these interventions
in order to facilitate appropriate integration into healthcare.
Because of the nature of multifaceted interventions such as
yoga and tai chi, it is imperative to design the best control
group(s) in order to minimize bias and maximize validity
and meet the specific needs of the research (see Table 3
for considerations about types of control groups in mind-
body research studies). Furthermore, in order to be consistent
with recommendations from the Consolidated Standards of
Reporting Trials (CONSORT) Statement, transparent report-
ing of decision making in control group design is an essential
aspect of the conduct of research on mind-body therapies
[33, 34].
3.1. Key Questions and Recommendations Regarding Control
Group Design. Based upon our brief review of the literature,
our experiences in designing RCTs on yoga and tai chi
for depression, and recommendations from the National
Institutes of Health, it is apparent that the researcher must
make careful decisions when designing the control group, in
order to hold asmany factors constant as possible between the
intervention and control conditions, in order to illuminate
the hypothesized mechanism of action [11, 35]. The following
key questions arise regarding appropriate study and control
group design:
(1) Does the study design match the research question?
(2) Does the control group address performance, expec-
tation, and detection bias?
(3) Is the control group ethical, feasible, and attractive?
(4) Does the control group control for nonspecific aspects
of the intervention?
Figure 1 provides a visual illustration of these questions
along with the important considerations and recommenda-
tions discussed herein.
First, in order to enhance the validity and applicability of
mind-body therapy research, the choice of the best control
group should be determined by the research question. The
current efficacy literature has tended toward the use of a
usual care or wait-list control group, and these designs are
traditionally considered to be somewhat “weak” because
there is no control for nonspecific treatment effects and it is
more difficult to differentiate the treatment effects [12, 35].
Future researchers should consider the following guidelines
regarding the goal of the research and the best study design:
(a) if a researcher seeks solely to establish efficacy and effec-
tiveness (i.e., determine whether and to what degree a mind-
body intervention may be helpful to depressed individuals),
the study design should evaluate within subjects and between
groups. As such, the suggested control group would be an
active control, a wait-list control, or a 3-arm design with an
active control group and a usual care control group; (b) If
the goal of the research is to determine appropriate dosing
of a mind-body intervention then the study may not include
a simple usual care group but rather would involve multiple
arms with varying duration/frequencies of the intervention
among the comparison groups. An “add-on” group or a
dismantling study may also be appropriate. However, efficacy
of the intervention must be determined prior to a dosing
study [9]. (c) If a researcher seeks to determine underlying
mechanisms for the effects of these interventions, then the
study designmust depend upon a theoretical frameworkwith
acknowledgement of plausible alternate hypotheses (see full
discussion in [1]). In this case, to enhance the rigor of the
study, the control groupwould be designed to actively control
for the alternative explanations for the possible effects of the
intervention (e.g., group effect/social support, attention from
study staff, therapeutic environment, etc.) [36].
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∗Explore with mixed
∗Ethics: usual care for clinical
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Figure 1: Key questions, considerations, and recommendations about control group design.
Second, the scientific community often calls for study
design to minimize performance, expectation, detection, and
selection bias [37]. However, the method for doing so usually
involves double- or triple-blinding and the use of placebo
controls, none of which are typically feasible in research on
mind-body modalities such as yoga and tai chi. Most often,
there are no reasonable options to serve as a placebo or a
“sham” intervention to allow for full blinding of participants
or researchers [38]. Despite this, researchers may consider
creative blinding methods, such as partially blinding partic-
ipants to the study hypothesis and blinding the data analysts
[7, 39]. Finally, researchers may overcome scientific concerns
about methodological rigor by providing detailed reports
of recruitment, randomization, and data analysis processes
using the guidelines from the CONSORT Statement and
those byBoutron and colleagues regardingmethods to extend
the CONSORT Statement to nonpharmacologic treatments
[7, 34].
Third, a consideration of the ethics, feasibility, and
attractiveness of a control group is always warranted. For
example, in research of mind-body complementary therapies
for depression, researchers must ask an important question:
what is a safe, ethical, and appropriate control group when
the clinical population is depressed? No-treatment groups
are not ethically reasonable because the usual care for
depression has been clinically established in the form of
psychoactive medications and psychotherapy. It is ethical to
expect that participants continue to receive this usual care
when a new intervention is tested. While the use of a simple
usual care control group is often the most feasible, this may
limit the attractiveness for potential participants. Despite
widespread use, the usual care for depression has many
limitations including patient reluctance to take medications,
lack of access to qualified psychotherapists related to cost or
availability, and patients being refractory to treatment, among
others [40]. Furthermore, researchers must consider how to
control for expectation and how to prevent the high rate
of attrition typically seen in control groups, particularly in
depressed study populations. Researchers often add elements
to the active control group that are attractive to those
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randomized to the group.The control group activitiesmust be
attractive enough tomaximize retentionwhile simple enough
to prevent significant changes in participants’ behavior [41].
Care must be taken to avoid enacting unintentional change
in participants in the control group [12]. Active control
group activities that deliver some kind of education may
end up changing participants’ behaviors and thus outcomes,
becoming an intervention in and of themselves.
Fourth, researchers must consider whether and how the
control group may account for nonspecific aspects of the
intervention such as the therapeutic environment, social
support, schedule and duration of practice of the treatment
and control activities, attention from study staff, and other
factors. For example, in research of an intervention for
depression, the usual care involves the standard unilateral
or bilateral approach of antidepressant drug therapy with
or without psychotherapy. In a usual care control group,
the participants would receive nothing more than these
standards of care. Alternatively, in an active control group,
the participants may continue to receive the usual care plus
a researcher-designed intervention that controls for some
aspects of the attention that the intervention group receives.
Ideally, the intervention group and the nonspecific active
control group should parallel one another with regard to
attention from and contact time with the research staff, time
spent in the research-related activities (from group meetings
to phone calls or length of involvement in weeks/months),
social support, follow-up times, and other similar factors;
this allows for any differences in the groups to be attributed
to the intervention itself, rather than these factors [12]. The
active control design is quite often ideal because it assists
in controlling for these nonspecific features of an interven-
tion such as number of visits, timing of the intervention,
and time/attention spent with participants. Ultimately, for
researchers designing a study of amind-body complementary
intervention for depression, the control group design that
may be most reasonable is the active control.
3.2. Additional Recommendations for the Future. Along with
the recommendations provided above, what else could be
done to optimize the design of a control group in future
larger-scale studies on mind-body modalities? There are a
few additional options that must be evaluated and carefully
considered, each with its own benefits and challenges.
Researchers must design a clear, detailed, and replicable
intervention which may ultimately simplify the type of
control group to use. One method may be the use of a
dismantling study, in which components of an intervention
are broken down and evaluated individually. One benefit of
these types of studies is that isolating individual components
of an intervention may allow for the intervention to be
kept as simple as possible and the optimum control activity
may become clear. For example, real-world mind-body inter-
ventions often involve a multitude of potentially beneficial
factors: gentle physical movement, relaxation, breathing,
mindfulness, calming music in the background, and guided
imagery, among others; it may be difficult to determine
whether one should control for these aspects. In a dismantling
study, the choices become more clear as a researcher chooses
to focus only on, say, the physicalmovement of yoga postures,
and therefore the control group would have to involve
another type of exercise (see Streeter and colleagues’ study
comparing yoga asana to a walking control group) [42]. This
could also be helpful for evaluating the cost-effectiveness of
an intervention such as yoga for depression.We acknowledge
that this is often not the real-world experience of these mind-
body therapies and that this could significantly decrease the
effect size of an outcome, yet a dismantling study may be
reasonable in some cases to allow for close examination of
the effects of certain components of the intervention and to
potentially enhance methodological rigor.
Researchers may also consider multiarm studies in
which various types of control and intervention groups are
used, particularly for considering comparative effectiveness.
Instead of dismantling potentially important components of
an intervention, as discussed in the previous paragraph, the
researcher may dismantle the location of the intervention
and control groups. For example, our intervention involved
both home and group classes which were time-intensive
and involved travel. Although we did find that participants
reported enjoying the group classesmore than home practice,
there was no way to compare whether one has a greater effect
than the other on depressive symptoms. A four-group design
could be implemented that dismantles the location of yoga,
with groups as follows: (1) usual care for depression, (2) usual
care + home yoga practice, (3) usual care + group yoga class,
and (4) usual care + group and home yoga practice.This may
assist, also, in controlling for the social support that often
inadvertently occurs in any group setting. The risk with this
type of dismantling may be that the similar interventions
could result in smaller effect sizes; additionally, the overall
sample size must be large enough to prevent a Type 2 error.
In addition, we highly recommend that researchers use
mixed methodologies in research on mind-body interven-
tions, in which both qualitative and quantitative approaches
are integrated in the study design. This is beneficial because
qualitative data may provide a more in-depth perspective on
participants’ experiences in both the intervention and control
activities, as we experienced in our recent clinical trials. For
example, participants may reveal in an interview whether
and how social interactions occurred within a treatment
or control group or may discuss individual variations in
life stresses and social resources. This qualitative data may
greatly enrich a study’s quantitative findings from psycho-
logical and physiological objective data. Despite the unique
challenges presented in the conduct of qualitative research
(e.g., bracketing research biases, among others; for more in-
depth discussions, see [43–46], among others), the benefits
outweigh the challenges and should be considered for the
value added to research of mind-body interventions.
As mentioned previously, in order to minimize bias and
enhance the validity of a study, researchers should consider
creative methods for blinding with regard to treatment
allocation and the study hypothesis. Inadequate concealment
of allocation and hypothesis may cause an exaggeration of
treatment effects due to participant and researcher expec-
tations [39, 47, 48]. Furthermore, inadequate concealment
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of the study hypothesis may lead to high rates of attrition
in a control group, whereby the control group participants
are less motivated to stay in a study if they perceive that a
“new, promising” intervention is more efficacious than the
standard treatment they are receiving [39]. To prevent these
issues, partial blinding of participants to the study hypothesis
may enhance retention and lend validity to study findings. In
addition, investigators and study staff should be blinded as
much as possible when conducting qualitative interviews and
data analysis in order to prevent observer bias.
Finally, researchers must be as transparent as possible
in their reporting of decision-making steps in study design,
guided by the CONSORT Statement and related revisions
[7, 33, 34]. Publications of research findings must include any
assumptions or decision points about the critical components
or unique aspects of an intervention and the control activity.
For example, it is important to acknowledge that there
may be additive effects of a yoga or tai chi intervention
based on the environment (pleasing appearance of room
or music playing), the personality, and skill set of study
staff/instructors, among others. For example, in designing
an appropriate control group for our yoga study, we clearly
designed the health education sessions to mirror the time,
location, and study staff attention as received in the yoga
group. Enhanced transparency of the conduct of a clinical
trial is necessary for other researchers to be able to evaluate
sources of bias, understand how an intervention was actually
administered, and even conduct meta-analyses [47]. For the
purpose of advancing the science and translating research
into clinical practice as well as making these therapies more
available to populations that may benefit from them, the goal
of well-designed research is to deliver valid conclusions. Clear
descriptions of interventions and control groups may be one
effective step to do so.
4. Conclusion
In conclusion, the state of the science in mind-body research
is that every systematic review has identified the need for
better methodology and more well-controlled studies. Con-
sidering the challenge in developing optimal controls, we
began with a brief focused review of control groups used in
pharmaceutical research. Given that the pharmaceutical sec-
tor’s gold standard of randomized and double-blinded design
does not typically apply in mind-body therapy research, we
briefly reviewed the types of control groups used in the
literature on yoga and tai chi for depression. To address the
methodological challenges of research onmind-bodymodal-
ities, we have reviewed key questions researchers should
ask when designing control groups and we have suggested
multiple ways to minimize bias and maximize validity. We
have focused our discussion and recommendations based
upon research of two types of mind-body interventions, yoga
and tai chi, for depression. However, the recommendations
here may be appropriately applied in other modalities and
conditions typically examined in complementary and alter-
native therapy research. Although we acknowledge that these
methods are not the only ways forminimizing complications,
we expect that this paper begins the discussion amongst
our research colleagues about these and other methods for
optimal research study design.
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